Abstract
Purpose
Effective treatment of patients with terminal heart failure and preserved ejection fraction (HFpEF) is an unmet medical need. The aim of this study was to investigate a novel valveless pulsatile pump as a therapeutic option for the HFpEF population through comprehensive in silico investigations.
Methods
The pump was simulated in a numerical model of the cardiovascular system of four HFpEF phenotypes and compared to a typical case of heart failure with reduced ejection fraction (HFrEF). The proposed pump, which was modeled as being directly connected to the left ventricle, features a single valveless inlet and outlet cannula and is driven in co-pulsation with the left ventricle. We collected hemodynamics for two different pump volumes (30 and 60 mL).
Results
In all HFpEF conditions, the 30 mL pump improved the cardiac output by approximately 1 L/min, increased the mean arterial pressure by > 11% and lowered the mean left atrial pressure by > 30%. With the larger (60 mL) stroke volume, these hemodynamic improvements were more pronounced. In the HFrEF condition however, these effects were three times less in magnitude.
Conclusions
In this simulation study, the valveless pulsatile device improves hemodynamics in HFpEF patients by increasing the total stroke volume. The hemodynamic benefits are achieved with a small device volume comparable to implantable rotary blood pumps.
Similar content being viewed by others
References
Agostoni, P., C. Vignati, P. Gentile, et al. Reference values for peak exercise cardiac output in healthy individuals. Chest. 151:1329–1337, 2017.
Birschmann, I., M. Dittrich, T. Eller, et al. Ambient hemolysis and activation of coagulation is different between HeartMate II and HeartWare left ventricular assist devices. J. Heart Lung Transpl. 33:80–87, 2014.
Borlaug, B. A. Heart failure with preserved ejection fraction. In: Management of heart failure2nd, Vol. 1, edited by R. Baliga, and G. Haas. New York: Springer, 2010, pp. 216–219.
Burkhoff, D., M. S. Maurer, S. M. Joseph, et al. Left atrial decompression pump for severe heart failure with preserved ejection fraction: theoretical and clinical considerations. JACC Heart Fail. 3:275–282, 2015.
Cecere, R., R. D. Dowling, and N. Giannetti. Initial clinical experience with the symphony heart assist system. Ann. Thorac. Surg. 99:298–301, 2015.
Colacino, F. M., F. Moscato, F. Piedimonte, et al. Left ventricle load impedance control by apical VAD can help heart recovery and patient perfusion: a numerical study. ASAIO J. 53:263–277, 2007.
Crow, S., C. Milano, L. Joyce, et al. Comparative analysis of von willebrand factor profiles in pulsatile and continuous left ventricular assist device recipients. ASAIO J. 56:441–445, 2010.
Diaphragm Gas Pumps—KNF. https://www.knf.com/products/oem-pumps/product/categories/diaphragm-gas-pumps/micro-pumps/. Accessed 30 Nov 2018.
Fresiello, L., B. Meyns, A. Di Molfetta, and G. Ferrari. A model of the cardiorespiratory response to aerobic exercise in healthy and heart failure conditions. Front. Physiol. 7:189, 2016.
Giridharan, G. A., C. Lederer, A. Berthe, et al. Flow dynamics of a novel counterpulsation device characterized by CFD and PIV modeling. Med. Eng. Phys. 33:1193–1202, 2011.
Gupta, S., K. Woldendorp, K. Muthiah, et al. Normalisation of haemodynamics in patients with end-stage heart failure with continuous-flow left ventricular assist device therapy. Heart Lung Circ. 23:963–969, 2014.
Haberl, T., J. Riebandt, S. Mahr, et al. Viennese approach to minimize the invasiveness of ventricular assist device implantation. Eur. J. Cardio-thorac. Surg. 46:991–996, 2014.
Hetzer, R., F. Kaufmann, and E. M. D. Walter. Paediatric mechanical circulatory support with berlin heart EXCOR: development and outcome of a 23-year experience. Eur. J. Cardio-thorac. Surg. 50:203–210, 2016.
Kasner, M., D. Sinning, J. Lober, et al. Heterogeneous responses of systolic and diastolic left ventricular function to exercise in patients with heart failure and preserved ejection fraction. ESC Heart Fail. 2:121–132, 2015.
Katz, D. H., L. Beussink, A. J. Sauer, et al. Prevalence, clinical characteristics, and outcomes associated with eccentric versus concentric left ventricular hypertrophy in heart failure with preserved ejection fraction. Am. J. Cardiol. 112:1158–1164, 2013.
Kirklin, J. K., F. D. Pagani, R. L. Kormos, et al. Eighth annual INTERMACS report: special focus on framing the impact of adverse events. J. Heart Lung Transpl. 36:1080–1086, 2017.
Klotz, S., M. L. Dickstein, and D. Burkhoff. A computational method of prediction of the end-diastolic pressure-volume relationship by single beat. Nat. Protoc. 2:2152–2158, 2007.
Krabatsch, T., I. Netuka, J. D. Schmitto, et al. Heartmate 3 fully magnetically levitated left ventricular assist device for the treatment of advanced heart failure-1 year results from the Ce mark trial. J. Cardiothorac. Surg. 12:23, 2017.
Landesberg, A., E. Konyukhov, R. Shofti, et al. Augmentation of dilated failing left ventricular stroke work by a physiological cardiac assist device. Ann. N. Y. Acad. Sci. 1015:379–390, 2004.
Landesberg, A., A. Shenhav, R. Shofty, et al. Effects of synchronized cardiac assist device on cardiac energetics. Ann. N. Y. Acad. Sci. 1080:466–478, 2006.
Li, J., P. M. Becher, S. Blankenberg, and D. Westermann. Current treatment of heart failure with preserved ejection fraction: should we add life to the remaining years or add years to the remaining life? Cardiol. Res. Pract. 1:1–9, 2013.
Loor, G., and G. Gonzalez-Stawinski. Pulsatile vs. continuous flow in ventricular assist device therapy. Best Pract. Res. Clin. Anaesthesiol. 26:105–115, 2012.
Lund, L. H., J. Matthews, and K. Aaronson. Patient selection for left ventricular assist devices. Eur. J. Heart Fail. 12:434–443, 2010.
Magder, S. Volume and its relationship to cardiac output and venous return. Crit. Care. 20:271, 2016.
Moscato, F., C. Wirrmann, M. Granegger, et al. Use of continuous flow ventricular assist devices in patients with heart failure and a normal ejection fraction: a computer-simulation study. J. Thorac. Cardiovasc. Surg. 145:1352–1358, 2013.
Muthiah, K., J. Phan, D. Robson, et al. Centrifugal continuous-flow left ventricular assist device in patients with hypertrophic cardiomyopathy. ASAIO J. 59:183–187, 2013.
Penicka, M., J. Bartunek, H. Trakalova, et al. Heart failure with preserved ejection fraction in outpatients with unexplained dyspnea. A pressure-volume loop analysis. J. Am. Coll. Cardiol. 55:1701–1710, 2010.
Rogers, J. G., F. D. Pagani, A. J. Tatooles, et al. Intrapericardial left ventricular assist device for advanced heart failure. N. Engl. J. Med. 376:451–460, 2017.
Shah, A. M., B. Claggett, N. K. Sweitzer, et al. Prognostic importance of impaired systolic function in heart failure with preserved ejection fraction and the impact of spironolactone. Circulation 132:402–414, 2015.
Sharma, K., and D. A. Kass. Heart failure with preserved ejection fraction: mechanisms, clinical features, and therapies. Circ. Res. 115:79–96, 2014.
Slaughter, M. S., J. G. Rogers, C. A. Milano, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N. Engl. J. Med. 361:2241–2251, 2009.
Slaughter, M. S., M. A. Sobieski, J. D. Graham, et al. Platelet activation in heart failure patients supported by the heartmate ii ventricular assist device. Int. J. Artif. Organs 34:461–468, 2011.
Topilsky, Y., N. L. Pereira, D. K. Shah, et al. Left ventricular assist device therapy in patients with restrictive and hypertrophic cardiomyopathy. Circ. Heart Fail. 4:266–275, 2011.
Uriel, N., P. C. Colombo, J. C. Cleveland, et al. Hemocompatibility-related outcomes in the MOMENTUM 3 trial at 6 months: a randomized controlled study of a fully magnetically levitated pump in advanced heart failure. Circulation 135:2003–2012, 2017.
Ursino, M. Interaction between carotid baroregulation and the pulsating heart: a mathematical model. Am. J. Physiol. 275:H1733–H1747, 1998.
Westerhof, N., J. W. Lankhaar, and B. E. Westerhof. The arterial windkessel. Med. Biol. Eng. Comput. 47:131–141, 2009.
Wolsk, E., R. Bakkestrøm, J. H. Thomsen, et al. The influence of age on hemodynamic parameters during rest and exercise in healthy individuals. JACC Heart Fail. 5:337–346, 2017.
Zile, M. R., C. F. Baicu, and W. H. Gaasch. Diastolic heart failure—abnormalities in active relaxation and passive stiffness of the left ventricle. N. Engl. J. Med. 19:1953–1959, 2004.
Acknowledgments
This work is part of the Zurich Heart project under the umbrella of “University Medicine Zurich”.
Funding
This study was funded by the UZH Foundation.
Conflict of interest
Marcus Granegger, Hitendu Dave, Walter Knirsch, Bente Thamsen, Martin Schweiger and Michael Hübler declare that they have no conflict of interest.
Ethical Approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Author information
Authors and Affiliations
Corresponding author
Additional information
Associate Editors Dr. Ajit P. Yoganathan and Dr. Ulrich Steinseifer oversaw the review of this article.
About this article
Cite this article
Granegger, M., Dave, H., Knirsch, W. et al. A Valveless Pulsatile Pump for the Treatment of Heart Failure with Preserved Ejection Fraction: A Simulation Study. Cardiovasc Eng Tech 10, 69–79 (2019). https://doi.org/10.1007/s13239-018-00398-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13239-018-00398-8